The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
Open Access
- 26 May 2009
- journal article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 4 (1) , 17
Abstract
Disease modifying anti-rheumatic drugs (DMARDs) may interfere with bone healing. Previous studies give conflicting advice regarding discontinuation of these drugs in the peri-operative setting. No consensus exists in current practice especially with the newer DMARDs such as Leflunomide, Etanercept, and Infliximab. The aim of this study was to assess the in-vitro effect of these drugs alone and in relevant clinical combinations on Osteoblast activity.Keywords
This publication has 42 references indexed in Scilit:
- Temporal effects of a COX‐2‐selective NSAID on bone ingrowthJournal of Biomedical Materials Research Part A, 2005
- COX inhibitors and their effects on bone healingExpert Opinion on Drug Safety, 2004
- COX inhibitors and their effects on bone healingExpert Opinion on Drug Safety, 2004
- Is methotrexate osteopathy a form of bone idiosyncrasy?Annals of the Rheumatic Diseases, 2003
- In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against ClinicalScedosporium prolificansIsolatesAntimicrobial Agents and Chemotherapy, 2003
- Cyclooxygenase-2 Inhibitor Inhibits the Fracture Healing.Journal of PHYSIOLOGICAL ANTHROPOLOGY and Applied Human Science, 2002
- Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgeryAnnals of the Rheumatic Diseases, 2001
- Leflunomide: mode of action in the treatment of rheumatoid arthritisAnnals of the Rheumatic Diseases, 2000
- IN VITRO EFFECTS OF METHOTREXATE ON HUMAN ARTICULAR CARTILAGE AND BONE-DERIVED OSTEOBLASTSRheumatology, 1996
- Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cellsJournal of Immunological Methods, 1992